A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00388700

Femme et Homme

  • | Pays :
  • Israel
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this clinical trial is to determine whether the combination of 5-fluorouracil (5-FU) plus a DAVANAT (carbohydrate polymer) along with Avastin and Leucovorin (LV) is beneficial in treating colorectal cancer in patients unable to tolerate intensive chemotherapy.


Critère d'inclusion

  • Colorectal Cancer

Liens